Saltar al contenido
Merck

In vivo partial reprogramming by bacteria promotes adult liver organ growth without fibrosis and tumorigenesis.

Cell reports. Medicine (2022-11-18)
Samuel Hess, Timothy J Kendall, Maria Pena, Keitaro Yamane, Daniel Soong, Linda Adams, Richard Truman, Anura Rambukkana
RESUMEN

Ideal therapies for regenerative medicine or healthy aging require healthy organ growth and rejuvenation, but no organ-level approach is currently available. Using Mycobacterium leprae (ML) with natural partial cellular reprogramming capacity and its animal host nine-banded armadillos, we present an evolutionarily refined model of adult liver growth and regeneration. In infected armadillos, ML reprogram the entire liver and significantly increase total liver/body weight ratio by increasing healthy liver lobules, including hepatocyte proliferation and proportionate expansion of vasculature, and biliary systems. ML-infected livers are microarchitecturally and functionally normal without damage, fibrosis, or tumorigenesis. Bacteria-induced reprogramming reactivates liver progenitor/developmental/fetal genes and upregulates growth-, metabolism-, and anti-aging-associated markers with minimal change in senescence and tumorigenic genes, suggesting bacterial hijacking of homeostatic, regeneration pathways to promote de novo organogenesis. This may facilitate the unraveling of endogenous pathways that effectively and safely re-engage liver organ growth, with broad therapeutic implications including organ regeneration and rejuvenation.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-β-actina monoclonal antibody produced in mouse, clone AC-74, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anticuerpo anti-Sox9, Chemicon®, from rabbit
Sigma-Aldrich
Anti-PCNA Antibody, clone PC10, clone PC10, Chemicon®, from mouse
Sigma-Aldrich
Anti-Goat IgG (H+L), highly cross-adsorbed, CF 568 antibody produced in donkey, ~2 mg/mL, affinity isolated antibody